Hyung-Jin Choi M.D., Ph.D
Seoul National University
Using Medical IP's AI and 3D medical image technology, our university has developed 3D digital anatomical education content for medical students, advancing toward a new era of metaverse anatomy education. We had the opportunity to compare technologies from various companies, and in terms of developing innovative educational content, Medical IP's products offered the most effective solution. Their technology was the most agile and flexible in innovating existing software and hardware, aligning with our vision to transform anatomy education into a metaverse-based learning experience. This collaboration allowed us to offer students the most groundbreaking medical education program, incorporating immersive 3D virtual reality anatomy dissection. We are leading a paradigm shift in anatomy education, integrating these technologies to establish a metaverse platform. We have collaborated with Medical IP and published several scientific papers in leading journals. Our randomized control study showed that virtual anatomy dissection's educational efficacy and satisfaction were superior to traditional cadaver anatomy dissection in a subgroup of students. We are committed to generating robust evidence supporting the educational effectiveness of this immersive 3D digital content.
Hee-Jin Kim, DDS, Ph.D
Yonsei University College of Dentistry
Medical IP’s virtual anatomy table is revolutionizing the field of anatomical education. This technology provides highly accurate 3D images that closely align with real anatomical structures, enabling students to intuitively understand the complexities of the human body. Traditional anatomy education often faces limitations due to time and resource constraints, but Medical IP’s solution overcomes these barriers, offering immersive learning experiences anytime and anywhere. Notably, by providing virtual cases such as fetuses and pregnant women, students can study anatomy in various scenarios without the need for actual cadavers. I am confident that Medical IP’s technology will become a core asset for future medical education and research, making a significant contribution to the advancement of anatomy.
Chul-Kee Park M.D., Ph.D
Seoul National University
Medical IP has various driving forces to visually implement the blueprint of the future medical field. Although there have been many difficulties, we have successfully established a clinical application platform for a patient-specific 3D brain disease model in the neurosurgery field and are in the standardization stage. Now, based on this track record, they are expanding into the AR/VR field. The ongoing process of developing a brain tumor diagnosis system based on AI technology brings me great joy and anticipation about the future that the result will bring to the medical field.
Seok-Soo Byun M.D., Ph.D
Seoul National University Bundang Hospital
Robotic partial nephrectomy for removal of kidney cancer performed along with MEDICAL IP’s 3D kidney surgical simulator was full of wonders for me. The simulators were similar not only in shape but also in texture and material to the real human organ and this let patients who witnessed their patient-specific 3D kidney models get a better understanding of their tumor. With the excellent 3D kidney surgical simulators provided by MEDICAL IP, we confirmed the successful clinical results and were able to publish these results. I am happy and grateful now that MEDICAL IP is making contributions for patients suffering from kidney cancer. I wish to continue this enjoyable journey with this company.
Park Jae Hyung, M.D., Ph.D
Chungnam National University Hospital
DeepCatch X represents a revolutionary leap forward in medical imaging technology. By extracting and providing critical metrics from a single chest X-ray, DeepCatch X offers specialized modules tailored to specific clinical needs such as DeepCatch X Aorta for detecting thoracic aortic enlargement, DeepCatch X Torso for measuring lung volume, DeepCatch X TB for identifying active tuberculosis, and DeepCatch X Pulmo for enhancing emphysema diagnosis. These modules are poised to set new benchmarks in both clinical and research applications.
DeepCatch X overcomes the inherent challenges of traditional 2D chest X-rays, such as overlapping structures, through advanced AI-powered visualization. By accurately identifying key measurements, like aortic diameter, and improving diagnostic precision such as suppressing bony structures to increase the visibility of soft tissues and lesions this technology dramatically enhances diagnostic workflows. It also fosters better communication and trust between healthcare providers and patients.
I am confident that DeepCatch X will elevate patient care to unprecedented levels by redefining diagnostic accuracy and efficiency, significantly advancing precision medicine and clinical practice.Hyung-Jin Choi M.D., Ph.D
Seoul National University
Using Medical IP's AI and 3D medical image technology, our university has developed 3D digital anatomical education content for medical students, advancing toward a new era of metaverse anatomy education. We had the opportunity to compare technologies from various companies, and in terms of developing innovative educational content, Medical IP's products offered the most effective solution. Their technology was the most agile and flexible in innovating existing software and hardware, aligning with our vision to transform anatomy education into a metaverse-based learning experience. This collaboration allowed us to offer students the most groundbreaking medical education program, incorporating immersive 3D virtual reality anatomy dissection. We are leading a paradigm shift in anatomy education, integrating these technologies to establish a metaverse platform. We have collaborated with Medical IP and published several scientific papers in leading journals. Our randomized control study showed that virtual anatomy dissection's educational efficacy and satisfaction were superior to traditional cadaver anatomy dissection in a subgroup of students. We are committed to generating robust evidence supporting the educational effectiveness of this immersive 3D digital content.Hee-Jin Kim, DDS, Ph.D
Yonsei University College of Dentistry
Medical IP’s virtual anatomy table is revolutionizing the field of anatomical education. This technology provides highly accurate 3D images that closely align with real anatomical structures, enabling students to intuitively understand the complexities of the human body. Traditional anatomy education often faces limitations due to time and resource constraints, but Medical IP’s solution overcomes these barriers, offering immersive learning experiences anytime and anywhere. Notably, by providing virtual cases such as fetuses and pregnant women, students can study anatomy in various scenarios without the need for actual cadavers. I am confident that Medical IP’s technology will become a core asset for future medical education and research, making a significant contribution to the advancement of anatomy.Chul-Kee Park M.D., Ph.D
Seoul National University
Medical IP has various driving forces to visually implement the blueprint of the future medical field. Although there have been many difficulties, we have successfully established a clinical application platform for a patient-specific 3D brain disease model in the neurosurgery field and are in the standardization stage. Now, based on this track record, they are expanding into the AR/VR field. The ongoing process of developing a brain tumor diagnosis system based on AI technology brings me great joy and anticipation about the future that the result will bring to the medical field.Seok-Soo Byun M.D., Ph.D
Seoul National University Bundang Hospital
Robotic partial nephrectomy for removal of kidney cancer performed along with MEDICAL IP’s 3D kidney surgical simulator was full of wonders for me. The simulators were similar not only in shape but also in texture and material to the real human organ and this let patients who witnessed their patient-specific 3D kidney models get a better understanding of their tumor. With the excellent 3D kidney surgical simulators provided by MEDICAL IP, we confirmed the successful clinical results and were able to publish these results. I am happy and grateful now that MEDICAL IP is making contributions for patients suffering from kidney cancer. I wish to continue this enjoyable journey with this company.Park Jae Hyung, M.D., Ph.D
Chungnam National University Hospital
DeepCatch X represents a revolutionary leap forward in medical imaging technology. By extracting and providing critical metrics from a single chest X-ray, DeepCatch X offers specialized modules tailored to specific clinical needs such as DeepCatch X Aorta for detecting thoracic aortic enlargement, DeepCatch X Torso for measuring lung volume, DeepCatch X TB for identifying active tuberculosis, and DeepCatch X Pulmo for enhancing emphysema diagnosis. These modules are poised to set new benchmarks in both clinical and research applications.
DeepCatch X overcomes the inherent challenges of traditional 2D chest X-rays, such as overlapping structures, through advanced AI-powered visualization. By accurately identifying key measurements, like aortic diameter, and improving diagnostic precision such as suppressing bony structures to increase the visibility of soft tissues and lesions this technology dramatically enhances diagnostic workflows. It also fosters better communication and trust between healthcare providers and patients.
I am confident that DeepCatch X will elevate patient care to unprecedented levels by redefining diagnostic accuracy and efficiency, significantly advancing precision medicine and clinical practice.
About Us
Make medical care more accurate
and understandable
Here at MEDICAL IP we are leading the future of healthcare with innovative technologies.
We are developing various medical imaging analysis technology based on AI and 3D technologies (3D printing, CAD/CAM, AR/VR) to reduce the time and cost of medical workload as well as the pain of patients. We are creating a future that will enable a better medical experience and service.
Technology that saves lives and helps with medical care is paramount.
We continuously research and develop new and innovative technologies that the medical field and world want.
We focus all of our abilities to develop accurate and precise technologies and products that medical staff and patients can trust.
We welcome and respect all opinions. We value the mutual growth of customers and employees.
7 consecutive years ‘Sample Vendor’
Inception Partner
‘1st Spin-off Start-up’
Exclusively Partnered with
VISION
Empowering Medicine, Saving Lives
MISSION
Research technology
that leads innovation
that leads innovation
Solve problems that arise
in medical field
in medical field
Develop medical solutions
that save lives
that save lives
2025
July
- Commenced supply of cardiovascular imaging analysis software DeepCatch X to 17 branches of the Korea Association of Health Promotion (KAHP)
June
- Liver cancer occurrence prediction solution DeepFore selected as 'Selection of the Month' in 'From the Editor Desk' of the Journal of Hepatology
- Liver cancer occurrence prediction solution DeepFore featured on the cover of the June issue of the Journal of Hepatology
May
- Liver cancer occurrence prediction solution DeepFore received MFDS approval (Class III medical device)
- Liver cancer occurrence prediction solution DeepFore published in the Journal of Hepatology, the top journal in the liver field (IF: 26.8)
April
- Medical imaging analysis software MEDIP Pro obtained NMPA certification in China (First among domestic AI companies)
- Medical imaging analysis software DeepCatch supplied to PUMC Hospital in China (First among domestic digital healthcare companies)
March
- Liver cancer recurrence prediction solution DeepFore Recur received MFDS approval (Class III medical device, first in the liver cancer field)
2024
September
- Medical imaging analysis software DeepCatch X Torso received MFDS certification (Class II medical device)
- Cardiovascular imaging analysis software DeepCatch X Heart received MFDS certification (Class II medical device)
August
- Cardiovascular imaging analysis software DeepCatch X Aorta received MFDS certification (Class II medical device)
July
- Secured SI investment from DK Medical Systems, a leading domestic X-ray system manufacturer
March
- Selected as one of the top 10 representative projects in the Korea Medical Device Development Fund (KMDF)
January
- Designated as an Innovative Medical Device Company by Ministry of Health and Welfare
2023
October
- Awarded the Minister of SMEs and Startups Award (Meritorious Contribution to Technological Innovation)
September
- Received the Innovation Grand Prize at the KHF Innovation Awards
August
- Selected as a reference company in Gartner Healthcare Provider (USA) for the 6th consecutive year
June
- Medical imaging analysis software DeepCatch received U.S. FDA Class II certification
March
- Signed 'Letter of Support' agreement with Amazon Web Services (AWS)
- Medical imaging analysis software TiSepX Lung Volumetry received MFDS certification (Class II medical device)
2022
November
- Awarded the Minister of Science and ICT Award
August
- Selected as a 'Premier Partner' in the NVIDIA Inception Program (USA)
- Selected as a reference company in Gartner Healthcare Provider (USA) for the 5th consecutive year
June
- Received dual A ratings in technology evaluation for KOSDAQ listing
March
- Medical imaging analysis software DeepCatch received MFDS certification (Class II medical device)
- Awarded the Minister of Health and Welfare Award
February
- Medical imaging analysis software MEDIP PRO received MFDS revised certification (Equipped with MEDIP PRO AR)
2021
December
- Awarded the Minister of Trade, Industry and Energy Award
November
- Selected among the Top 100 National R&D Excellence Achievements 2021 by the Ministry of Science and ICT
September
- Medical imaging analysis software MEDIP PRO obtained MHRA certification in the UK
August
- Selected as a reference company in Gartner Healthcare Provider (USA) for the 4th consecutive year
May
- Secured strategic investment from Dong-A Socio Holdings
2020
November
- Selected as one of the 'National Representative 1000 Innovative Companies' by the Financial Services Commission and as a '4th Batch Innovation Icon' by the Korea Credit Guarantee Fund
- Awarded the Minister of SMEs and Startups Award
October
- Medical imaging analysis software MEDIP Pneumovid received MFDS approval (Class III medical device)
September
- Medical 3D printing solution ANATDEL received MFDS approval (Class I medical device)
August
- Selected as a reference company in Gartner Healthcare Provider (USA) for the 3rd consecutive year
May
- Selected as an excellent DNA (Data, Network, AI) company by the Ministry of Science and ICT
March
- Developed 'MEDIP COVID19' software specialized for COVID-19 and distributed it worldwide for free
2019
December
- Awarded the Minister of Science and ICT Award and the Mayor of Chuncheon Award
- Medical imaging analysis software MEDIP PRO obtained European CE/MDD and ISO 13485 certifications
November
- Medical imaging analysis software MEDIP PRO received U.S. FDA Class II certification
August
- Selected as a reference company in Gartner Healthcare Provider (USA) for the 2nd consecutive year
2018
July
- Selected as a reference company in Gartner Healthcare Provider (USA) (First in Asia)
2016
November
- Medical imaging analysis software MEDIP received MFDS manufacturing certification (Class II medical device)
June
- Certified as a venture business by the Korea Technology Finance Corporation
May
- Recognized as an affiliated research institute by the Korea Industrial Technology Association
2015
September
- Established Medical IP Co., Ltd.
Testimonials
MEDICAL IP KOREA
Laboratory : 806~809, SNUCRI, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea
MEDICAL IP USA
MEDICAL IP CHINA